Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma Virus.
- Published in:
- Oncolytic Virotherapy, 2019, v. 8, p. 57, doi. 10.2147/OV.S220420
- By:
- Publication type:
- Article
Works matching IS 22531572 AND DT 2019 AND VI 8
Results: 6
1
2
Virus–Receptor Interactions: Structural Insights For Oncolytic Virus Development.
- Published in:
- Oncolytic Virotherapy, 2019, v. 8, p. 39, doi. 10.2147/OV.S218494
- By:
- Publication type:
- Article
3
Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma.
- Published in:
- Oncolytic Virotherapy, 2019, v. 8, p. 27, doi. 10.2147/OV.S196403
- By:
- Publication type:
- Article
4
Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes.
- Published in:
- Oncolytic Virotherapy, 2019, v. 8, p. 9, doi. 10.2147/OV.S176523
- By:
- Publication type:
- Article
5
A cautionary note on the selectivity of oncolytic poxviruses.
- Published in:
- Oncolytic Virotherapy, 2019, v. 8, p. 3, doi. 10.2147/OV.S189832
- By:
- Publication type:
- Article
6
Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma [Corrigendum].
- Published in:
- Oncolytic Virotherapy, 2019, v. 8, p. 1, doi. 10.2147/OV.S196145
- By:
- Publication type:
- Article